Introduction
============

Prior non-invasive ventilation (NIV) is associated with an increased mortality in patients with haematological malignancies and acute respiratory failure treated by invasive mechanical ventilation (IMV).

Methods
=======

We have assessed whether NIV failure is an independent prognostic factor for hospital discharge in a general cancer population treated by IMV. One hundred and six patients with solid tumours and 58 patients with haematological malignancies were eligible for this retrospective study; 41 were treated by NIV before IMV.

Results
=======

The main indications for mechanical ventilation were sepsis/shock (35%), acute respiratory failure (33%), cardiopulmonary resuscitation (16%) and neurologic disease (10%). Respectively, 35%, 28% and 24% of the patients were extubated, discharged from the ICU and from the hospital. For patients treated with NIV prior to IMV, the rates were 22%, 17% and 10%, respectively. In multivariate analysis, three variables were independently associated with a decreased probability of being discharged from the hospital: NIV use before IMV (OR = 0.30, 95% CI: 0.09 to 0.95; *P*= 0.04); leucopenia (OR = 0.21, 95% CI: 0.06 to 0.77; *P*= 0.02) and serum bilirubin \>1.1 mg/dl (OR = 0.38, 95% CI: 0.16 to 0.94; *P*= 0.04).

Conclusions
===========

NIV failure before IMV is an independent poor prognostic factor in cancer patients treated by IMV.
